SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-22-009897
Filing Date
2022-09-20
Accepted
2022-09-20 16:16:05
Documents
1
Period of Report
2022-09-16

Document Format Files

Seq Description Document Type Size
1 tbph-form4_091622.html 4  
1 tbph-form4_091622.xml 4 6808
  Complete submission text file 0001387131-22-009897.txt   8514
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GSK PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 221253859
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations